Directory
>
Justine Cunningham
Justine Cunningham
Postdoctoral fellow | REGENXBIO
Maryland, Rockville, United States
Justine Cunningham
Summary
Justine Cunningham is a seasoned executive with extensive experience in nonclinical development and toxicology within the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Nonclinical Development at RegenX Bio, she is dedicated to advancing cell and genetic therapies into clinical testing. Justine has held leadership roles at several notable organizations, including Sana Biotechnology and Allergan, where she specialized in toxicology, biodistribution, and pharmacology. With a robust academic background, including a PhD in Neuroscience from The University of Queensland, she combines scientific expertise with strategic oversight. Her passion for innovation is evident in her work on preclinical models and regulatory submissions, contributing significantly to the field of gene therapy. Justine also shares her knowledge as an adjunct instructor, emphasizing the importance of clear communication in scientific documentation.
Justine Cunningham
Work Experience
VP, Nonclinical Development at
REGENXBIO
May 2023 - Present
Justine Cunningham
Education
The University of Queensland, BSc (HonsI), PhD, Anatomy (Neuroscience)
January 1988 - January 1997
Frequently Asked Questions about Justine Cunningham
What is Justine Cunningham email address?
Justine Cunningham's primary email address is ******************@sana.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Justine Cunningham work for?
Justine Cunningham is a Postdoctoral fellow at REGENXBIO.
Where Justine Cunningham graduated from?
Justine Cunningham holds a degree in null from The University of Queensland.
How can I directly contact Justine Cunningham?
To contact Justine Cunningham directly, you can use the email address ******************@sana.com. Complete contact information is available upon registration with Muraena.
Who is Justine Cunningham?
Justine Cunningham is a seasoned executive with extensive experience in nonclinical development and toxicology within the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Nonclinical Development at RegenX Bio, she is dedicated to advancing cell and genetic therapies into clinical testing. Justine has held leadership roles at several notable organizations, including Sana Biotechnology and Allergan, where she specialized in toxicology, biodistribution, and pharmacology. With a robust academic background, including a PhD in Neuroscience from The University of Queensland, she combines scientific expertise with strategic oversight. Her passion for innovation is evident in her work on preclinical models and regulatory submissions, contributing significantly to the field of gene therapy. Justine also shares her knowledge as an adjunct instructor, emphasizing the importance of clear communication in scientific documentation.
Justine`s contact details
******************@sana.com
***********@regenxbio.com
Colleagues
Clinical Coordinator
Sr Clinical Research Associate
Assistant Scientist
Senior Medical Scientist
Database Administrator
Postdoctoral Fellow
Sr. Statistician
Process Engineer / Process Development Scientist
QA Auditor
Assistant Professor- School of Pharmacy